New combo pill tested in healthy volunteers – no treatment given
NCT ID NCT07046975
First seen Mar 14, 2026 · Last updated May 09, 2026 · Updated 8 times
Summary
This study looked at how a new extended-release tablet combining two heart medications (torsemide and spironolactone) is absorbed and processed by the body. It involved 24 healthy adults aged 18 to 45. The goal was to measure drug levels in blood and urine, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIOAVAILABILITY HEATHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sarfez Pharmaceuticals
Vienna, Virginia, 22182, United States
Conditions
Explore the condition pages connected to this study.